Meredith

Grant Wood CEO, GGMC Steering Committee, G2MC Technology Executive in Clinical Genomics, USA Grant Wood has 17 years experience with a major US healthcare system, designing and leading development of computer systems that support healthcare providers and researchers in advancing and delivering genomic-based clinical care. He has a breadth of knowledge in all aspects of … Read more

Scott Sundseth, Ph.D. Advisory Board Member, GGMC Program Director, IHCC Founder, Sundseth Consulting, LLC Sundseth has applied pharmacogenomic analysis to drug discovery and development across multiple therapeutic areas and for diverse healthcare enterprises for over 30 years. As Founder of Sundseth Consulting and Chief Scientific Officer at Cabernet Pharmaceuticals, Sundseth has advised clients on how … Read more

Geoff Ginsburg, M.D., Ph.D. Advisory Board Member, GGMC Co-Chair, IHCC Chief Medical and Scientific Officer, All of Us Research Program, National Institutes of Health Professor of Medicine, Pathology and Biomedical Engineering, Duke University, USA Geoffrey Ginsburg, M.D., Ph.D., is the Chief Medical and Scientific Officer of the All of Us Research Program at the National … Read more

Gabriela Repetto, M.D. Board of Directors, GGMC Co-Chair, G2MC Professor of Genetics, Facultad de Medicina, Clinica Alemana Universidad del Desarrollo, Santiago, Chile Dr. Repetto is a Clinical Geneticist and Director of the Center for Genetics and Genomics at Facultad de Medicina Clinica Alemana Universidad del Desarrollo in Santiago, Chile, a leading clinical, teaching and research … Read more

Catalina Lopez-Correa, M.D., Ph.D. Board of Directors, GGMC Co-Chair, G2MC Executive Director, Genome Canada Dr. Lopez-Correa is Executive Director of the Canadian COVID19 Genomics Network (CanCOGen) with Genome Canada. In this capacity, she is coordinating efforts across Canada to sequence human and viral genomes and use the data to help shape policy and public health … Read more